A biopharmaceutical player that could be setting up to break out is Vivus (VVUS), which is engaged in the development and commercialization of therapeutic drugs for large underserved markets, including for sleep apnea, diabetes and men's sexual health. This stock hasn't done much so far this year, with shares off by around 5%.
If you take a look at the chart for Vivus, you'll see that this just ran up big from its August low of $6.13 a share to its current price of just over $8.70 a share. During that uptrend, the stock was acting very bullish, making higher highs and higher lows. As long as that pattern of higher highs and higher lows continues, then this stock is going to continue to trend higher.
Market players should now watch for a breakout in Vivus that sustains a move above some previous overhead resistance at $9.07 a share. Just yesterday, the stock hit $9.62 a share on massive volume of 4.9 million shares, but since then it's pulled back below the breakout level of $9.07. This could mean the breakout attempt was a failure, or it could mean the stock wants to fill a gap to $8.50 before it starts another trend higher.Related: 11 Biotech Stocks With Hedge Fund Activity If you're bullish on Vivus, you could buy the stock once it clears $9.07 again on big volume. Look for volume that's tracking in close to or well above its three-month average volume of 1.5 million shares. If this stock does break out again, then I would add to any long position once it clears $9.62 on solid volume. You could also buy the stock off any significant weakness and anticipate the breakout. I would use a stop at around $8 a share in case the bears take back control of this stock in the near future. Keep in mind that this is a heavily shorted stock with over 19.3% of the float sold short by the bears. If this stock breaks out in the coming weeks or days again, then watch for a high volume move that could lead to a massive short-squeeze. I also included Vivus on a recent list of 5 Stocks Under $10 Setting Up to Trade Higher.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV